Stifel maintains Halliburton stock Buy rating, $42 target
Stifel analysts maintained a Buy rating and a $42.00 price target for Halliburton (NYSE:HAL), following the company's fourth-quarter earnings report for 2024. With a current P/E ratio of 10.3x and an ...
Stifel maintains Procter & Gamble stock hold with $161 target
Stifel analysts maintained a Hold rating on Procter & Gamble stock (NYSE:PG) with a steady price target of $161.00. The ...
Edgewise rated as a new Hold at Stifel on a balanced risk-reward setup
Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a ...
ABL Advisor2h
Alpaca Real Estate Closes $50MM Credit Facility with Stifel Bank
Alpaca Real Estate (“ARE”), an alternative investment management firm, closed a $50 million credit facility with Stifel Bank. This financing marks another key milestone in the firm’s growth, ...
Cytokinetics initiated with a Buy at Stifel
Stifel initiated coverage of Cytokinetics (CYTK) with a Buy rating and $80 price target Cytokinetics “is an out-of-favor stock” following the ...
Edgewise Therapeutics initiated with a Hold at Stifel
Stifel initiated coverage of Edgewise Therapeutics (EWTX) with a Hold rating and $30 price target The firm says that while Edgewise has “very ...
bovnews23h
Why Did Stifel Give Altimmune Inc (ALT) Stock Buy Rating?
Altimmune Inc (ALT) stock saw a modest uptick, ending the day at $6.86 which represents a slight increase of $0.15 or 2.24% from the prior close of $6.71. The stock opened at $6.8 and touched a low of ...